Join
Live feed
·
INSIDERFilingvia Quantisnow
enGene Therapeutics Inc. logo

Chief Executive Officer Cooper Ronald Harold Wilfred bought $57,000 worth of shares (10,000 units at $5.70) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ENGN· enGene Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENGN (enGene Therapeutics Inc.) and more on Quantisnow.